METASTATIC RENAL CANCER
Clinical trials for METASTATIC RENAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug cocktail targets Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests whether a combination of three drugs (sasanlimab, palbociclib, and axitinib) can shrink tumors in people with advanced kidney cancer that has spread. About 25 adults with clear cell or translocation renal cell carcinoma will receive the drugs and be monitored for…
Matched conditions: METASTATIC RENAL CANCER
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated May 26, 2026 11:45 UTC
-
New combo therapy aims to extend life for advanced kidney cancer patients
Disease control Recruiting nowThis study looks at whether adding a precise type of radiation called SABR to standard targeted therapy and immunotherapy can help people with kidney cancer that has come back or spread. The goal is to improve how long the cancer stays under control and possibly extend survival. …
Matched conditions: METASTATIC RENAL CANCER
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 26, 2026 11:45 UTC
-
Smart scans aim to zap kidney cancer spread with precision radiation
Disease control Recruiting nowThis study tests whether adding a special type of PET/CT scan (CAIX-targeted) to standard treatment can help doctors precisely target and radiate kidney cancer that has spread. About 70 adults with recurrent or metastatic clear cell renal cell carcinoma will receive standard ther…
Matched conditions: METASTATIC RENAL CANCER
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC